MENU
MLTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

MoonLake Immunotherapeutics (MLTX) Earnings Date & Reports

MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases... Show more

A.I. Advisor
published Earnings

MLTX is expected to report earnings to rise 3.35% to -74 cents per share on May 08

MoonLake Immunotherapeutics MLTX Stock Earnings Reports
Q1'25
Est.
$-0.74
Q4'24
Missed
by $0.12
Q3'24
Missed
by $0.12
Q2'24
Missed
by $0.11
Q1'24
Missed
by $0.02
The last earnings report on February 26 showed earnings per share of -72 cents, missing the estimate of -60 cents. With 318.77K shares outstanding, the current market capitalization sits at 2.30B.
View a ticker or compare two or three
MLTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
Dorfstrasse 29
Phone
+41 415108022
Employees
50
Web
https://www.moonlaketx.com